Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lilly's E-Venture Fund: Getting In At The Bottom

This article was originally published in Start Up

Executive Summary

With investors still generally staying out of e-health, a couple of Big Pharma companies think it's time to get in. First, Merck & Co. Inc. announced last November that former Merck-Medco chairman, Per Lofberg would head a $100 million fund dedicated to Internet Health care. And now, Eli Lilly & Co. has just launched the $50 million e.Lilly Venture Fund. Lilly's fund, which will focus on companies with technologies that the company can use, rather than return on investment, will make investments of up to $3 million in 12 to 15 companies over the next year or so.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC090362

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel